OPRX
OptimizeRx CorpCompany Information
- Company Name
- OptimizeRx Corp
- CIK
- CIK0001448431
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- OPRX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 07 Trade & Services
- SIC
- 7389
- SIC Description
- Services-Business Services, NEC
- Ticker
- OPRX
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-03-14
- Last sale
- 2025-12-19
- Shares purchased (TTM)
- 321,408
- Shares sold (TTM)
- 14,128
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 10,757,022
- Shares outstanding
- 18,785,596
- Ownership
- 57.26%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -10.36%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patents | 4 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Technology Based Intangible Assets | 6 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Customer Relationships | 28 | - | - | - | - | - | - | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 24 | 20 | 23 | 20 | 17 | 17 | 13 | 16 | 15 | 15 | 14 | 10 | ||||||
| Short Term Investments | - | - | - | - | - | - | - | - | - | - | - | 54 | ||||||
| Accounts Receivable Net Current | 25 | 32 | 38 | 32 | 34 | 33 | 38 | 26 | 25 | 30 | 36 | 21 | ||||||
| Income Taxes Receivable | 2 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 2 | 1 | 1 | - | ||||||
| Prepaid Expense And Other Assets Current | - | - | - | - | - | - | 2 | 4 | 5 | 2 | 3 | - | ||||||
| Prepaid Expense Current | 3 | 3 | 3 | 3 | 3 | 2 | 2 | - | - | - | - | 3 | ||||||
| Assets Current | 54 | 56 | 65 | 56 | 54 | 52 | 54 | 47 | 46 | 48 | 54 | 87 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Assets | ||||||||||||||||||
| Goodwill | 71 | 71 | 71 | 71 | 71 | 71 | 71 | 71 | 78 | 78 | 78 | 23 | ||||||
| Finite Lived Patents Gross | - | - | - | - | - | - | - | - | - | - | - | 2 | ||||||
| Deferred Costs | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Other Intangible Assets Net | - | - | - | - | - | - | - | - | 14 | 15 | 34 | 3 | ||||||
| Finite Lived Intangible Assets Net | 39 | 40 | - | 5 | 5 | 5 | - | 6 | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | ||||||
| Deposits Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | 1 | - | ||||||
| Other Long Term Investments | - | - | - | - | - | - | - | - | 0 | 1 | - | 1 | ||||||
| Security Deposit | - | - | - | - | - | - | 0 | 0 | - | - | 1 | - | ||||||
| Other Assets | 110 | 111 | 112 | 114 | 115 | 116 | 117 | - | - | - | 129 | 36 | ||||||
| Assets | 164 | 167 | 177 | 170 | 169 | 168 | 171 | 165 | 173 | 176 | 183 | 124 | ||||||
Liabilities Current | ||||||||||||||||||
| Long Term Debt Current | 1 | 2 | 4 | 3 | 3 | 3 | 2 | 2 | 3 | 4 | 2 | - | ||||||
| Accounts Payable Trade Current | 1 | 3 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 2 | 2 | 1 | ||||||
| Accrued Liabilities Current | 5 | 4 | 12 | 10 | 12 | 9 | 8 | 6 | 5 | 7 | 8 | 3 | ||||||
| Taxes Payable Current | - | - | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | - | - | 1 | 1 | 0 | 0 | ||||||
| Contract With Customer Liability Current | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | ||||||
Non Current Liabilities | ||||||||||||||||||
| Liabilities Current | 10 | 10 | 21 | 18 | 21 | 18 | 19 | 15 | 15 | 17 | 18 | 8 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Long Term Debt Noncurrent | 18 | 21 | 21 | 25 | 25 | 29 | 31 | 33 | 32 | 32 | 34 | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Income Tax Liabilities Net | 6 | 6 | 6 | 4 | 3 | 4 | 4 | 3 | 4 | 4 | 4 | - | ||||||
| Liabilities | 33 | 38 | 49 | 48 | 50 | 51 | 54 | 51 | 52 | 54 | 57 | 8 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Value | - | - | -0 | - | - | - | -0 | - | - | - | - | - | ||||||
| Treasury Stock Value | -0 | -0 | - | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Additional Paid In Capital | 211 | 209 | 208 | 207 | 204 | 203 | 201 | 199 | 196 | 194 | 191 | 176 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -80 | -80 | -79 | -84 | -85 | -87 | -84 | -84 | -75 | -71 | -64 | -60 | ||||||
| Stockholders Equity | 131 | 130 | 128 | 122 | 119 | 116 | 117 | 114 | 121 | 123 | 127 | 116 | ||||||
| Liabilities And Stockholders Equity | 164 | 167 | 177 | 170 | 169 | 168 | 171 | 165 | 173 | 176 | 183 | 124 | ||||||
| Allowance For Doubtful Accounts Receivable | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Shares Outstanding | 19 | 19 | - | - | - | 18 | - | - | - | - | - | 18 | ||||||
| Common Stock Shares Authorized | 167 | 167 | 167 | 167 | 167 | 167 | 167 | 167 | 167 | 167 | 167 | 167 | ||||||
| Common Stock Shares Issued | 21 | 21 | 21 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 18 | ||||||
| Treasury Stock Common Shares | 2 | - | 2 | 2 | 2 | - | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOptimizeRx Corp (OPRX) — SEC Financial Statements & Analysis
OptimizeRx Corp (OPRX) is a services-business services, nec company, incorporated in NV. OptimizeRx Corp trades on Nasdaq as: OPRX. OptimizeRx Corp (OPRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, OptimizeRx Corp carries a market cap of $107.45M, a P/E ratio of 23.35x, a P/B ratio of 0.82x, a P/S ratio of 1.07x, an enterprise value of $102.36M, and an EV/EBITDA multiple of 8.07x. On profitability, it posts a gross margin of 65.25%, an operating margin of 8.34%, a net margin of 4.57%, a Return on Equity (ROE) of 3.68%, a Return on Assets (ROA) of 2.76%, and a Return on Invested Capital (ROIC) of 3.35%. Per share, it reports EPS of $0.24, diluted EPS of $0.24, free cash flow per share of $0.98, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -1.73% year-over-year, net income growth of -146.62% year-over-year, and EPS growth of -145.93% year-over-year. On the balance sheet, it maintains a current ratio of 5.58x, a quick ratio of 5.27x, working capital of $44.44M, a debt-to-equity ratio of 0.25x, a debt ratio of 0.2, an interest coverage ratio of 1.80x, free cash flow of $18.36M (TTM), and net debt of $-5.09M. Figures sourced from SEC EDGAR.
- Market Cap
- $107.45M
- P/E TTM
- 23.35x
- EPS TTM
- $0.24
- P/B TTM
- 0.82x
- ROE TTM
- 3.68%
- ROA TTM
- 2.76%
- Debt To Equity
- 0.25x
- Free Cash Flow TTM
- $18.36M
- Net Revenue TTM Growth 1Y
- -1.73%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is OptimizeRx Corp in?
OptimizeRx Corp (OPRX) operates in the Services-Business Services, NEC industry.
What exchange does OPRX trade on?
OptimizeRx Corp (OPRX) trades on the Nasdaq.
Where is OptimizeRx Corp incorporated?
OptimizeRx Corp is incorporated in NV.
When was OptimizeRx Corp (OPRX)'s most recent SEC filing?
OptimizeRx Corp (OPRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is OPRX's market cap?
OptimizeRx Corp (OPRX) has a market capitalization of $107.45M as of 2026-06-30.
What is OPRX's P/E ratio?
OptimizeRx Corp (OPRX)'s trailing twelve month P/E ratio is 23.35x as of 2026-06-30.
What is OPRX's EPS (earnings per share)?
OptimizeRx Corp (OPRX)'s trailing twelve month EPS is $0.24 as of 2026-06-30.
What is OPRX's ROE (return on equity)?
OptimizeRx Corp (OPRX)'s trailing twelve month Return on Equity (ROE) is 3.68% as of 2026-06-30.
What is OPRX's ROA (return on assets)?
OptimizeRx Corp (OPRX)'s trailing twelve month Return on Assets (ROA) is 2.76% as of 2026-06-30.
What is OPRX's ROIC (return on invested capital)?
OptimizeRx Corp (OPRX)'s trailing twelve month Return on Invested Capital (ROIC) is 3.35% as of 2026-06-30.
What is OPRX's EV/EBITDA?
OptimizeRx Corp (OPRX)'s trailing twelve month EV/EBITDA is 8.07x as of 2026-06-30.